Literature DB >> 32677251

Predicting Patterns of Regulatory Behavior in the Still-Face Paradigm at 3 Months.

Miguel Barbosa1,2, Marjorie Beeghly3,4, Joana L Gonçalves5, João Moreira1, Edward Tronick6,7, Marina Fuertes8,9.   

Abstract

The current study addressed two aims: (1) to describe different patterns of infant regulatory behavior during the Face-to-Face Still-Face (FFSF) paradigm at 3 months of age and (2) to identify specific, independent predictors of these patterns from an a priori set of demographic, infant (e.g., temperament), and maternal (e.g., sensitivity) variables. Analyses were based on data collected for 121 mother-infant dyads assessed longitudinally in the newborn period and again at 3 months. In the newborn period, infants' neurobehavior was evaluated using the Neonatal Behavioral Assessment Scale (NBAS) and mothers reported on their caregiving confidence and their newborns' irritability and alertness. At 3 months, mothers reported on their infant's temperament, and mother-infant interactions were videotaped during free play and the FFSF. Three patterns of infant regulatory behavior were observed. The most common was a Social-Positive Oriented Pattern, followed by a Distressed-Inconsolable Pattern, and a Self-Comfort Oriented Pattern. Results of multinomial logistic regression indicated that categorical assignment was not associated with demographic or infant characteristics, but rather with dyadic regulatory processes in which maternal reparatory sensitivity played a crucial role. © International Congress of Infant Studies (ICIS).

Entities:  

Year:  2019        PMID: 32677251     DOI: 10.1111/infa.12293

Source DB:  PubMed          Journal:  Infancy        ISSN: 1532-7078


  1 in total

1.  Family SES and maternal sensitivity predict infant patterns of regulatory behavior in Brazilian dyads.

Authors:  Camila da Costa Ribeiro; Ana Teresa Hernandes Teodoro; Pedro Lopes Dos Santos; Dionísia Aparecida Cusin Lamônica; Marina Fuertes
Journal:  Early Hum Dev       Date:  2020-09-29       Impact factor: 2.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.